Testosterone is an important part of women's hormonal health, influencing sexual desire, arousal, and satisfaction. Beyond sexual health, several promising studies have reported improvements in mood, energy, sense of well-being, and menopausal symptoms such as hot flashes and night sweats. These findings are generating growing interest in testosterone's broader therapeutic potential for women.
Yet despite growing interest in testosterone therapy for women, clinical guidelines remain relatively narrow. The strongest evidence supports its use for postmenopausal women diagnosed with hypoactive sexual desire disorder (HSDD) - essentially, low sexual desire that causes personal distress.
Arriving at this diagnosis involves evaluating anxiety, depression, medications, and relationship issues. All reasonable considerations, although women navigating menopause might understandably roll their eyes at having their psychological well-being and relationships scrutinized before anyone considers their hormones.
The conversation is evolving, and the direction is exciting. Research from Dr. Rebecca Glaser and others is expanding our understanding of testosterone's potential benefits beyond sexual health. These encouraging findings deserve greater attention, research funding, and larger randomized controlled trials to validate the results and help guide future treatment recommendations.
At Kass Precision Medicine in Seattle and Bellevue, we believe women's symptoms and treatment goals deserve thoughtful consideration - not simply interpretation through a narrow diagnostic label.
The Role of Testosterone in Women's Health
Testosterone is an essential hormone in women, produced by the ovaries and adrenal glands and through the conversion of other hormones in peripheral tissues. Although women have substantially lower circulating testosterone concentrations than men, androgens participate in multiple physiological processes, including sexual function and signaling in the brain, muscles, and other tissues.
Testosterone concentrations generally decline with age, although the relationship between testosterone levels and menopausal symptoms is not straightforward. Natural menopause does not produce the same abrupt decline in testosterone that occurs with estrogen. Testosterone levels can be a data point, but treatment decisions are primarily guided by symptoms, as there is no single optimal testosterone level for all women. Laboratory results should be interpreted in the context of each woman’s symptoms and goals.
Benefits of Testosterone Therapy for Women
The strongest clinical evidence for testosterone therapy involves sexual desire and sexual function in postmenopausal women. Research is also examining its potential effects on other aspects of midlife health.
Sexual Desire, Arousal, and Satisfaction
Testosterone plays an important role in female sexual desire, arousal, and satisfaction. Clinical trials have demonstrated meaningful improvements in sexual function among postmenopausal women receiving testosterone therapy.
Much of the research focuses on women diagnosed with hypoactive sexual desire disorder (HSDD) - persistently low sexual desire that causes personal distress. The diagnostic process includes evaluating other potential contributors, such as anxiety, depression, medications, and relationship concerns. All reasonable considerations, although women navigating menopause might understandably roll their eyes at having their psychological well-being and relationships scrutinized before their hormones enter the conversation.
Sexual desire is complex, and hormonal changes deserve consideration alongside - not after - these other factors.
Clinical trials have demonstrated improvements in several aspects of sexual function, including:
Sexual desire and interest
Arousal and responsiveness
Vaginal lubrication
Orgasmic function
Sexual pleasure and satisfaction
Reduction in distress related to low desire
A major meta-analysis found that conservative testosterone therapy dosing increased satisfying sexual events by approximately one per month compared with placebo, on average.
Current guidelines favor testosterone dosing within the physiological female range. However, treatment response varies, and some clinicians are exploring more individualized approaches to dosing. The benefits and long-term safety of higher-than-physiological levels need further study.
Energy, Fatigue, and Physical Well-Being
Fatigue, reduced stamina, and diminished vitality are common concerns during the menopause transition.
Although these symptoms are multifactorial, testosterone's physiological activity in muscle and other tissues has prompted investigation into whether supplementation may improve energy and physical well-being.
Several observational studies have reported improvements in fatigue and physical symptoms following testosterone therapy.
A 2026 study published in The Journal of Sexual Medicine evaluated 279 perimenopausal and menopausal women who added transdermal testosterone after receiving conventional hormone therapy. Researchers reported improvements in multiple symptom categories, including energy, musculoskeletal symptoms, and overall menopausal symptom burden.
These findings are encouraging, particularly for women whose symptoms persist despite treatment with estrogen and progesterone. However, this was a retrospective study, and randomized controlled trials with a placebo or comparison group are needed to confirm these findings. More randomized trials are needed to establish if testosterone can consistently improve metrics like energy and fatigue.
Mood, Motivation, and Cognitive Symptoms
Testosterone influences several pathways in the brain involved in mood, motivation, and cognitive function, including neurotransmitter signaling. Its role in psychological well-being is well recognized in men, with clinical studies demonstrating improvements in depressive symptoms and quality of life in certain populations receiving testosterone therapy.
There is growing interest in these potential benefits for women. Some women receiving testosterone therapy report improvements in mood, motivation, concentration, and mental clarity, and emerging clinical research is beginning to examine these outcomes more closely.
A 2025 retrospective study published in Archives of Women's Mental Health evaluated 510 perimenopausal and postmenopausal women who added transdermal testosterone to their existing hormone therapy. After four months, approximately 47% reported improvements in mood and 39% reported improvements in cognitive symptoms.
These findings are encouraging and consistent with testosterone's known activity in the brain. However, the study was retrospective, and larger randomized controlled trials are needed to confirm these benefits in women.
Estrogen decline and fluctuations are well-established contributors to mood and cognitive changes during menopause and should be addressed. Testosterone may also play a role, particularly when symptoms persist despite estrogen therapy. Sleep, metabolic health, and other hormonal factors are also important considerations.
Hot Flashes, Night Sweats, and Other Menopausal Symptoms
Estrogen therapy remains the most effective established hormonal treatment for menopausal vasomotor symptoms, including hot flashes and night sweats.
Nevertheless, emerging research has examined whether testosterone may provide additional symptom relief in selected women.
In a 2011 study published in Maturitas, Rebecca Glaser, MD, and colleagues evaluated 300 premenopausal and postmenopausal women receiving testosterone implants. Participants reported improvements across psychological, somatic, and urogenital symptom categories after three months of treatment.
More recently, the 2026 Journal of Sexual Medicine study reported improvements in hot flashes and other menopausal symptoms among women receiving transdermal testosterone in addition to conventional hormone therapy.
These findings suggest that testosterone may have broader effects on menopausal symptom burden than previously appreciated.
These findings are particularly encouraging and suggest that testosterone may offer benefits well beyond sexual health, including relief from hot flashes, night sweats, and other menopausal symptoms. Research from Dr. Rebecca Glaser and others is helping expand our understanding of testosterone's role in women's health. We hope this growing body of evidence will attract the funding and larger randomized controlled trials needed to further validate these promising results.
What Does the Research Tell Us About Testosterone Beyond Sexual Health?
Research into testosterone therapy for women is expanding beyond sexual health, with encouraging findings involving mood, cognition, energy, physical well-being, and menopausal symptoms.
Several studies are helping shape this evolving understanding:
Glaser et al., Maturitas (2011): In 300 women receiving testosterone implants, researchers reported improvements across psychological, physical, and urogenital symptoms measured by the Menopause Rating Scale. Read the study.
Glynne et al., Archives of Women's Mental Health (2025): Among 510 women who added transdermal testosterone to existing hormone therapy, 47% reported improvements in mood and 39% in cognitive symptoms after four months. Read the study.
The Journal of Sexual Medicine (2026): A study of 279 women adding transdermal testosterone to hormone therapy found significant improvements in 15 of 24 assessed symptoms, including hot flashes, energy, mood, cognition, and musculoskeletal complaints. Read the study.
These findings are exciting because they suggest testosterone may have a much broader role in women's health than traditionally recognized. While these studies were observational, they provide compelling reasons to invest in larger randomized controlled trials to confirm the benefits and better understand which women may benefit most.
Who May Benefit From Testosterone Therapy?
Testosterone therapy may be considered for postmenopausal women experiencing persistent, distressing low sexual desire following a comprehensive assessment.
This evaluation should consider hormonal and nonhormonal contributors, including:
Menopausal symptoms and changes in sexual function
Sleep quality and fatigue
Vaginal dryness or pain with sexual activity
Medication effects
Mood and psychological health
Relationship factors
Relevant medical and endocrine conditions
Women in late reproductive life or perimenopause may also experience distressing low desire. Limited evidence supports consideration of testosterone in selected women in this group, although the strongest clinical trial evidence remains in postmenopausal patients.
Testosterone therapy is not appropriate for every woman, and treatment decisions should be based on clinical assessment rather than an isolated laboratory value.
How Is Testosterone Dosed and Delivered for Women?
What Is the Right Testosterone Dose for Women?
There is no single dose that works for every woman. Women vary considerably in how they absorb, metabolize, and respond to testosterone, which is why treatment should be individualized.
The goal is to find a dose that provides meaningful symptom relief while minimizing unwanted side effects, such as acne, increased facial hair, or scalp hair thinning.
Current guidelines recommend maintaining testosterone within the normal physiological range for premenopausal women. At Kass Precision Medicine, we consider symptoms, treatment response, laboratory findings, and tolerability rather than relying on a single testosterone number.
What Are the Different Ways to Take Testosterone?
Testosterone therapy for women is commonly delivered through a compounded cream or gel. There is no FDA-approved commercial testosterone product formulated for women in the United States at this time. Other options include injections and pellets, each with its own advantages and considerations.
How Is Testosterone Therapy Monitored?
Monitoring comes down to two important questions: Is treatment helping, and is it well tolerated?
At Kass Precision Medicine, we evaluate symptom improvement, potential side effects, and laboratory findings to guide treatment adjustments.
Our goal is to help women achieve meaningful benefits from testosterone therapy while maintaining an appropriate balance between effectiveness and safety.
Creams & Gels
Advantages: Applied to the skin, daily. Allow flexible dosing and easy adjustments. Compounded formulations can provide doses tailored to women.
Considerations: Requires daily application and precautions to prevent transfer to others. Compounded testosterone is not FDA-approved but prescribed through regulated compounding pharmacies.***
Injections
Advantages: Convenient for women who prefer not to apply medication daily. Dosing can be adjusted as needed.
Considerations: Require injections and may cause fluctuations in testosterone levels depending on the dosing schedule.
Pellets
Advantages: Provide sustained testosterone delivery over 3-4 months without daily application.
Considerations: Require a minor insertion procedure and are difficult to adjust or discontinue once implanted. Can lead to high levels.
*** While FDA-approved medications are generally preferred when available, compounded testosterone is a commonly used alternative for women. Compounding pharmacies are regulated and subject to inspection by state pharmacy boards and must follow established quality and safety standards.
Is Testosterone Therapy Safe for Women?
When testosterone is prescribed at physiological female doses, short-term randomized trial data have shown a favorable safety profile in postmenopausal women.
Nevertheless, treatment requires attention to potential adverse effects and areas of uncertainty.
Potential Side Effects
Androgen-related side effects may include:
Acne or increased skin oiliness
Increased facial or body hair
Hair shedding or thinning in susceptible women
Changes in voice, more likely in excessive or high doses
Clitoral enlargement, particularly with excessive doses
Some androgenic effects may be irreversible.
The risk of adverse effects increases with higher testosterone doses.
Cardiovascular and Breast Health
The safety research on testosterone therapy for women has been encouraging. Randomized clinical trials have not demonstrated an increased risk of serious adverse cardiovascular events or breast cancer incidence with testosterone therapy in women. Studies have also found no significant adverse effects on blood pressure, blood glucose, or breast density, and short-term transdermal testosterone has not been associated with increased breast cancer risk.
Longer-term observational research offers additional reasons for optimism. Dr. Rebecca Glaser's research reported lower rates of breast cancer among women receiving testosterone implants compared with expected population rates. These findings are particularly interesting and warrant further investigation, although they do not establish that testosterone prevents breast cancer.
Overall, the evidence to date is reassuring. Larger, longer-term randomized trials are needed to better establish cardiovascular and breast safety. At Kass Precision Medicine, we consider each woman's medical history and individual risk profile when recommending treatment.
How Is Testosterone Therapy Monitored?
At Kass Precision Medicine, monitoring starts with the patient, not just a laboratory number. Regular follow-up allows us to assess symptom improvement, treatment response, and potential side effects, such as acne, facial hair growth, or scalp hair thinning. Laboratory testing provides additional information to help guide safe, individualized dosing.
The Kass Precision Medicine Approach to Testosterone Therapy
At Kass Precision Medicine, we look beyond routine lab results to understand what's changed, what isn't working, and what women want to improve. Testosterone is one part of a broader conversation about hormones, health, and quality of life.
1. Looking at the Whole Hormonal Picture
We evaluate symptoms, sexual health, sleep, mood, energy, medical history, and relevant laboratory findings to identify what may be contributing to how a woman feels.
2. Building a Treatment Plan That Makes Sense
We consider testosterone alongside estrogen, progesterone, and other factors affecting health, with treatment decisions guided by symptoms, clinical findings, and patient goals.
3. Following Through
We stay involved. Regular conversations about what's improving, what's not, and how treatment is being tolerated help us make meaningful adjustments over time.
Frequently Asked Questions About Testosterone Therapy for Women
What are the main benefits of testosterone therapy for women?
Testosterone has well-established benefits for sexual desire, arousal, and satisfaction in postmenopausal women with HSDD. Promising studies have also reported improvements in energy, mood, motivation, cognitive symptoms, and menopausal complaints such as hot flashes and night sweats. These broader findings are generating excitement and deserve further investigation in larger clinical trials.
Can testosterone improve energy and motivation during menopause?
Potentially. Testosterone plays a role in brain pathways involved in motivation, mood, and well-being. Several observational studies have reported improvements in energy, fatigue, and motivation among women receiving testosterone therapy. These encouraging findings warrant larger randomized trials to better understand who benefits most.
Does testosterone help with hot flashes and night sweats?
Emerging research suggests it may. Studies, including Dr. Rebecca Glaser's work, have reported improvements in hot flashes and night sweats among women receiving testosterone therapy. Estrogen remains the most effective established hormonal treatment for these symptoms, but testosterone's potential additional benefits are an exciting area for further research.
Can testosterone improve mood or brain fog?
Possibly. Testosterone influences neurotransmitter pathways involved in mood and cognitive function. Recent studies have reported improvements in mood, concentration, and mental clarity among women receiving treatment. Larger randomized trials are needed to confirm these findings, but the results offer promising directions for menopause research.
Is testosterone therapy appropriate during perimenopause?
Testosterone may be considered for selected women during perimenopause, particularly those experiencing distressing changes in sexual desire. Research in perimenopausal women is more limited than in postmenopausal women, but interest in its potential benefits during this transition is growing.
Will testosterone cause masculinizing side effects?
Not necessarily. Most women tolerate appropriately dosed testosterone well. Possible side effects include acne, increased facial hair, and scalp hair thinning, particularly with excessive exposure. More pronounced androgenic effects, such as voice deepening, are uncommon at recommended doses. Careful dosing and regular clinical follow-up help minimize these risks.
Is testosterone therapy FDA-approved for women?
There is currently no FDA-approved testosterone product specifically for women in the United States. However, testosterone is prescribed off-label in women's hormone care, often using compounded creams or gels that allow dosing appropriate for women.
How long does testosterone therapy take to work?
Some women notice improvements in sexual desire and responsiveness within several weeks, although benefits often develop gradually. A meaningful assessment of treatment response generally takes three to six months. The timeline for potential benefits involving mood, energy, or other menopausal symptoms is less well established.
Menopause Care That Looks Beyond the Basics
Women in midlife are often navigating demanding careers, families, and full lives while experiencing changes in sleep, energy, sexual health, and overall well-being. These symptoms deserve more than reassurance that everything is "normal." At Kass Precision Medicine, we take women's concerns seriously, look beyond routine testing, and explore the treatment options that may help them feel and function at their best.